ArticleSensors (Basel, Switzerland)2026
A Robust Current-Feedback Operational Amplifier-Based Front-End Amplifier for Electrocardiogram Signal Noise Removal.
Article in Sensors (Basel, Switzerland), 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
This paper introduces an electrocardiogram (ECG) noise removal front-end amplifier circuit based on a current-feedback operational amplifier (CFOA) that uses the current feedback to detect error signals and control the output. This ECG circuit focuses on denoising the ECG noise to accentuate the ECG electrical signals from the heart. Noises in ECG refer to baseline wander (BW), powerline interference (PLI) and motion artifacts. We proposed a CFOA-based ECG pre-amplifier using the AD844 commercial operational amplifier built inside with a positive second-generation current conveyor (CCII+) and a voltage follower circuit. This work introduces an ECG noise removal front-end amplifier based on a CFOA. The primary innovation lies in the balancing instrumentation amplifier architecture that utilizes the high-speed and robust properties of the AD844 commercial operational amplifier to achieve superior noise rejection. To protect against high-frequency interference, we introduce a novel cascaded low-pass filter (LPF) stage that ensures a sharper cut-off compared to traditional single-stage designs. Experimental results validate the design's effectiveness, achieving a high common-mode rejection ratio (CMRR) of 75.4 dB and a mid-band gain of 46.5 dB. These performance metrics, combined with the circuit's ability to eliminate BW and PLI, confirm its robust suitability for high-fidelity wearable ECG monitoring.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.